| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_71b944100daf03103e6704d7474fd127 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-1282
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0478 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-12 |
| filingDate |
2001-10-19^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f91feadc42b3688816b08e9ea3c2a5ef
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b2ddeaa762f2911bc34be02b6d13bf07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9de4d371c56de666a06d7644b6f4d1c9 |
| publicationDate |
2004-04-07^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1404376-A2 |
| titleOfInvention |
Radiopharmaceutical formulations |
| abstract |
A method is described for inhibiting the degradation of a diagnostic or radiotherapeutic radiopharmaceutical, especially radiolabeled compounds containing reducible moieties, by including oxidants either as a part of the composition for the preparation of such radiopharmaceuticals, or by adding an oxidant to such compositions immediately after the preparation of such radiopharmaceuticals. |
| priorityDate |
2000-10-19^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |